377 related articles for article (PubMed ID: 18387855)
1. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.
Churi SB; Abdel-Aleem OS; Tumber KK; Scuderi-Porter H; Taylor BK
J Pain; 2008 Jul; 9(7):639-49. PubMed ID: 18387855
[TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
Morgenweck J; Abdel-Aleem OS; McNamara KC; Donahue RR; Badr MZ; Taylor BK
Neuropharmacology; 2010 Feb; 58(2):337-45. PubMed ID: 19891980
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
4. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
Hao GH; Niu XL; Gao DF; Wei J; Wang NP
Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
[TBL] [Abstract][Full Text] [Related]
5. Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury.
Genovese T; Cuzzocrea S; Di Paola R; Mazzon E; Mastruzzo C; Catalano P; Sortino M; Crimi N; Caputi AP; Thiemermann C; Vancheri C
Eur Respir J; 2005 Feb; 25(2):225-34. PubMed ID: 15684285
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
8. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats.
Zhao X; Zhang Y; Strong R; Grotta JC; Aronowski J
J Cereb Blood Flow Metab; 2006 Jun; 26(6):811-20. PubMed ID: 16208315
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
11. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1.
Benkirane K; Amiri F; Diep QN; El Mabrouk M; Schiffrin EL
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H390-7. PubMed ID: 16155101
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
[TBL] [Abstract][Full Text] [Related]
13. The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development.
Takahashi Y; Hasegawa-Moriyama M; Sakurai T; Inada E
Anesth Analg; 2011 Aug; 113(2):398-404. PubMed ID: 21490083
[TBL] [Abstract][Full Text] [Related]
14. Spinal neuroimmune activation inhibited by repeated administration of pioglitazone in rats after L5 spinal nerve transection.
Jia HB; Wang XM; Qiu LL; Liu XY; Shen JC; Ji Q; Yang JJ
Neurosci Lett; 2013 May; 543():130-5. PubMed ID: 23583338
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Maffia P; Patel NS; Di Paola R; Ialenti A; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Eur J Pharmacol; 2004 Jan; 483(1):79-93. PubMed ID: 14709329
[TBL] [Abstract][Full Text] [Related]
16. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
[TBL] [Abstract][Full Text] [Related]
17. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
[TBL] [Abstract][Full Text] [Related]
19. Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway.
Ye F; Sun T; Luo H; Ding H; Chen K; Shen X; Jiang H
Cell Physiol Biochem; 2006; 18(1-3):143-50. PubMed ID: 16914899
[TBL] [Abstract][Full Text] [Related]
20. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
